Clinical trials
Withdrawn Myelodysplastic Syndromes trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Florida | 3 |
| Fred Hutchinson Cancer Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Traws Pharma, Inc. | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Bellicum Pharmaceuticals | 1 |
| Bio-Path Holdings, Inc. | 1 |
| City of Hope Medical Center | 1 |
| Cornerstone Pharmaceuticals | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 36 |
| Leukemia, Myeloid, Acute | 20 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 |
| Leukemia | 6 |
| Myeloproliferative Disorders | 6 |
| Recurrence | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 |
| Leukemia, Myeloid, Chronic-Phase | 5 |
| Leukemia, Myelomonocytic, Chronic | 5 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.